# Agalsidase Alfa (Genetical Recombination) for I.V. Infusion 3.5mg (リプレガル点滴静注用３．５ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3959410A1025). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3959410A1025
- **Product name (Japanese):** リプレガル点滴静注用３．５ｍｇ
- **English title:** Agalsidase Alfa (Genetical Recombination) for I.V. Infusion 3.5mg
- **Active ingredient:** アガルシダーゼアルファ（遺伝子組換え）
- **Active ingredient (INN):** Agalsidase Alfa (Genetical Recombination)
- **Strength / unit:** ３．５ｍｇ３．５ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 395 Enzyme preparations (酵素製剤)
- **Manufacturer:** Takeda Pharmaceutical (武田薬品工業)
- **NHI price (reference only):** JPY 255011 per ３．５ｍｇ３．５ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3959410A1025
- **JSON:** https://www.nifujipharma.com/api/drugs/3959410A1025

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Agalsidase%20Alfa%20(Genetical%20Recombination)%20for%20I.V.%20Infusion%203.5mg%20(%E3%83%AA%E3%83%97%E3%83%AC%E3%82%AC%E3%83%AB%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%93%EF%BC%8E%EF%BC%95%EF%BD%8D%EF%BD%87)%20%2F%20YJ%203959410A1025#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.